TY - JOUR
T1 - Concordancia de las pruebas de tuberculina e Interferón gamma en población reclusa.
AU - Marco Mouriño, A.
AU - Orcau Palau, A.
AU - Jané Galliga, R.
AU - Escribano Ibáñez, M.
AU - Caylà Buqueras, J. A.
AU - Solé Zapata, N.
AU - del Baño Hollín, L.
AU - Quintero del Río, S.
AU - Ferrer Escobar, M. D.
AU - Mangues Bafalluy, J.
AU - Guerrero Moreno, R. A.
AU - Martín Sánchez, V.
N1 - Funding Information:
This work was sponsored by the Check Point Institute for Information Security; by European Union’s Tenth Framework Programme (FP10/2010-2016) under grant agreement 259426 ERC-CaC, by the the Leona M. & Harry B. Helm-sley Charitable Trust; by the Israeli Ministry of Science and Technology; by the Israeli Centers of Research Excellence I-CORE program (center 4/11); and by NATO’s Public Diplomacy Division in the Framework of ”Science for Peace”.
PY - 2011
Y1 - 2011
N2 - To study the agreement of Tuberculin Skin Tests (TST) and Interferon Gamma Release Assays (IGRA) when screening tuberculosis infection amongst inmates recently admitted to prison. Prospective study conducted in a prison during the months of May and June 2009. Inmates without a TB history, with previous TST negatives or without prior TSTs were included. Participants signed an informed consent form and the study was approved by an independent Ethical Committee. TST (positive 10 > or = mm) and IGRA (Quantiferon TB-Gold) were performed and standardized data collection was carried out. The agreement between both tests was analysed using the Kappa index. A total of 181 people were included. 62% were foreign-born, 17% had previous BCG vaccination, 8.4% were IDUs and 4% HIV-infected. Foreign born subjects were more frequently vaccinated and presented less drug use and HIV infection than people born in Spain. (p=0.02, p=0.02 and p=0.01 respectively). TST results were positive in 24% and IGRA in 26%. Both tests were performed in 149 people (82%). Discordant results were observed in 15.8%. Agreement of the Kappa coefficient was 0.6 (CI 0.4-0.7). Agreement was better in the native population (K=0.8) and worse in BCG vaccinated (K=0.4) and foreign-born subjects (K=0.8). Overall agreement was moderate and was less amongst vaccinated subjects and those born abroad. Extension of the study could be useful to evaluate which test better predicts the risk of progression to active TB and the cost-benefit of both tests among the prison population.
AB - To study the agreement of Tuberculin Skin Tests (TST) and Interferon Gamma Release Assays (IGRA) when screening tuberculosis infection amongst inmates recently admitted to prison. Prospective study conducted in a prison during the months of May and June 2009. Inmates without a TB history, with previous TST negatives or without prior TSTs were included. Participants signed an informed consent form and the study was approved by an independent Ethical Committee. TST (positive 10 > or = mm) and IGRA (Quantiferon TB-Gold) were performed and standardized data collection was carried out. The agreement between both tests was analysed using the Kappa index. A total of 181 people were included. 62% were foreign-born, 17% had previous BCG vaccination, 8.4% were IDUs and 4% HIV-infected. Foreign born subjects were more frequently vaccinated and presented less drug use and HIV infection than people born in Spain. (p=0.02, p=0.02 and p=0.01 respectively). TST results were positive in 24% and IGRA in 26%. Both tests were performed in 149 people (82%). Discordant results were observed in 15.8%. Agreement of the Kappa coefficient was 0.6 (CI 0.4-0.7). Agreement was better in the native population (K=0.8) and worse in BCG vaccinated (K=0.4) and foreign-born subjects (K=0.8). Overall agreement was moderate and was less amongst vaccinated subjects and those born abroad. Extension of the study could be useful to evaluate which test better predicts the risk of progression to active TB and the cost-benefit of both tests among the prison population.
UR - http://www.scopus.com/inward/record.url?scp=80052326160&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052326160&partnerID=8YFLogxK
M3 - Article
C2 - 21484074
AN - SCOPUS:80052326160
SN - 1575-0620
VL - 13
SP - 15
EP - 20
JO - Revista española de sanidad penitenciaria
JF - Revista española de sanidad penitenciaria
IS - 1
ER -